We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immunofluorescence Assay Developed for Hantaviruses

By LabMedica International staff writers
Posted on 15 Apr 2013
Print article
Image: transmission electron micrograph (TEM) of the Sin Nombre virus (Photo courtesy of Cynthia Goldsmith).
Image: transmission electron micrograph (TEM) of the Sin Nombre virus (Photo courtesy of Cynthia Goldsmith).
Simultaneous tests were developed for clinically important Old and New World hantaviruses using multiparametric indirect immunofluorescence assays (IFAs) based on biochip mosaics.

To detect serum antibodies each of the mosaic substrates consisted of cells infected with one of the virus types Hantaan (HTNV), Puumala (PUUV), Seoul (SEOV), Saaremaa (SAAV), Dobrava (DOBV), Sin Nombre (SNV) or Andes (ANDV).

Scientists from the Euroimmun Medizinische Labordiagnostika AG, ( Luebeck, Germany) in collaboration with others, analyzed 184 laboratory-confirmed Hantavirus-positive sera collected at six diagnostic centers from patients actively or previously infected with different Hantavirus serotypes. The control panel comprised 89 sera from healthy blood donors. The Euroimmun’s Hantavirus Mosaic 1 and 3 were used for the multiparametric IFA-based detection of Hantavirus-specific immunoglobulin G (IgG) and IgM.

The overall qualitative performance of multiparametric IFAs in detecting anti-Hantavirus antibodies was analyzed by considering those samples as seropositive that showed specific reactivity with a cut-off 1:100, against at least one of the different Hantavirus serotypes contained in the biochip mosaics. In the multiparametric IFA applied in the study, 99% of the patient sera were IgG positive and 71% were IgM positive. Overall IFA sensitivity for combined IgG and IgM analysis amounted to 100% for all serotypes, except for SNV, which was 96%. Of the 89 control sera, 2% showed IgG reactivity against the HTNV substrate, but not against any other Hantavirus.

The authors concluded that analysis of Hantavirus-specific IgG and IgM by indirect immunofluorescence on substrate mosaics consisting of cells infected with different hantaviruses is a globally applicable. The method is a reliable diagnostic tool for screening of patients suspected of having Hantavirus infection, and can be useful for serotyping in areas where hantaviruses of different serogroups are endemic. The multiparametric IFA enables highly sensitive and specific serological diagnosis of Hantavirus infections and can be used to differentiate PUUV and ANDV infection from infections with Murinae-borne hantaviruses such as DOBV and SEOV. The study was published on April 4, 2013, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
Euroimmun Medizinische Labordiagnostika AG


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.